DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Max Healthcare Institute Limited — Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

NSE 1 hr ago·19 Aug 2026, 4:35 pm

Company NSE

Max Healthcare Institute has informed stock exchanges that it is disclosing a matter under SEBI regulations. This disclosure relates to pending litigation or disputes that could potentially impact the company's business or financial position.

For investors, this development is important because it signals that the company is being transparent about potential legal risks. While the specific details of the dispute have not been disclosed, such information is crucial for investors to make informed decisions about their holdings in the healthcare sector.

Investors should watch for further updates from the company or the exchange regarding the nature of the dispute. The outcome of this litigation will be a key factor to monitor for assessing the company's future stability and operational risks.